← Eichor
Study identifier: NCT03883022 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Vancomycin Powder Combined With Autogenous Bone Graft as a Prevention for Post-operative Infection for Spine Surgery

Condition: Spinal Fusion · Spinal Stenosis · Spondylolisthesis  ·  Sponsor: Taipei Veterans General Hospital, Taiwan

PhaseNA
Planned participants400
Who can joinAll sexes, 20 Years to no upper limit
Healthy volunteersNo

About this study

Deep surgical site infection (DSSI) is one of the most challenging complications for spinal surgeons and can lead to a poor clinical outcome. This ambispective study was designed to examine the effect of vancomycin powder mixed with autogenous bone graft and bone substitute on preventing deep surgical site infection (DSSI) in degenerative lumbar fusion surgeries as well as any interference with bony fusion.

This description comes directly from the study's public registry record.

Talk to the study team

Shih-Tien Wang, MD  ·  886-2-28757557  ·  stwang@vghtpe.gov.tw

Always discuss trial participation with your own doctor first.

Locations (1)

Taipei Veterans General HospitalTaipei, TaiwanRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03883022